The medication requires ongoing use to maintain weight loss, as demonstrated in the SURMOUNT-4 trial, where discontinuation led to weight regain
Mumbai - 400066 / Om Sai Aradhana, Borivali East Vendor Details Country of origin: United states MRP 8973.05 Save more with additional offers Flat Rs.150 on a Min Transaction of Rs.1000
Semaglutide primarily acts as a GLP- 1 agonist, while Tirzepatide combines GLP- 1 and GIP mechanisms, enhancing its effectiveness for weight loss
Which molecule has the best GI tolerability
After completing a short quiz to confirm basic eligibility, patients fill out a more detailed medical intake covering health history, current medications, lifestyle habits, and weight loss goals
CJC-1295 (No DAC): This is a modified, shorter-acting version of GHRH